Home - Gastroenterology Advisor
While HIPAA rules protect health information of patients in hospitals and for physician visits, generally they do not protect the privacy or security of a patient’s health and wellness information when it is created accessed through or stored on personal cell …
Clinician Insights on How to Manage Semaglutide-Induced …
Sep 8, 2023 · Patients who receive treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, such as semaglutide, may experience delayed gastric emptying due to the drug’s mechanism of action (MOA). 1 Symptoms may include nausea, vomiting, heartburn, pain, or bloating. 2 However, the symptoms of delayed gastric emptying resulting from GLP-1 receptor agonists may be similar to symptoms of ...
What We Know About Semaglutide Adverse Events and …
Sep 1, 2023 · What Are Other Causes of Gastroparesis? Diabetes is the most common underlying cause of gastroparesis and can damage the vagus nerve, leading to impaired muscular function in the stomach and small intestine. 3 Studies show that the 10-year cumulative incidence of diabetic gastroparesis is estimated to be 5.2% among patients with type 1 diabetes and 1% in patients with type 2 diabetes. 4
Long-Term Budesonide for Microscopic Colitis Is Effective …
Sep 20, 2023 · Budesonide efficaciously controls moderate to severe symptoms of microscopic colitis (MC) with a low risk for adverse effects from long-term use, according to study findings published in Inflammatory Bowel Diseases.. The inflammation that occurs in MC makes the colon less effective in absorbing liquid from the contents traveling through the bowel, often resulting in chronic diarrhea ...
News and Features - Gastroenterology Advisor
While HIPAA rules protect health information of patients in hospitals and for physician visits, generally they do not protect the privacy or security of a patient’s health and wellness information when it is created accessed through or stored on personal cell …
Gastroparesis Awareness Month: Updated Guidelines to Treat …
Aug 19, 2022 · The American College of Gastroenterology (ACG) released updated clinical guidelines on managing gastroparesis (GP). The new recommendations were published in The American Journal of Gastroenterology.. GP is characterized by delayed gastric emptying (GE) of solid food in the absence of mechanical obstruction.
News Archive - Gastroenterology Advisor
Oct 11, 2024 · Clarithromycin administered via a dispersible tablet has a higher Helicobacter pylori (H pylori) eradication rate than clarithromycin sustained-release tablets, according to study results published in Therapeutic Advances in Gastroenterology.
GERD and the Elderly Patient: Clinical Considerations
Jan 7, 2020 · Patients with gastroesophageal reflux disease (GERD) are frequently referred to gastroenterologists. As patients get older GERD is more common, with a prevalence of 20% or higher in the outpatient setting. 1 Elderly patients with GERD can clinically present differently than younger patients and their management may therefore vary. A review article published by Dr M Kurin of the Digestive ...
FDA Alert: Gastroenterology Drug Approvals and New Indications
Sep 27, 2024 · Over the summer, the US Food and Drug Administration (FDA) approved a biosimilar for Crohn disease (CD) and ulcerative colitis (UC), a blood-based test for colorectal cancer (CRC) screening, a new indication for heartburn associated with nonerosive gastroesophageal reflux disease (GERD), a new indication for UC, and a new indication for younger patients with progressive familial intrahepatic ...
Chronic Idiopathic Constipation: 10 Recommendations for …
Jun 9, 2023 · The American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG) have jointly developed a clinical practice guideline regarding the pharmacological management of patients with chronic idiopathic constipation (CIC), as published in the American Journal of Gastroenterology and Gastroenterology.. The guideline provides 10 evidence-based recommendations for ...